These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 25471063)

  • 1. Complete remission of Schnitzler syndrome and Waldenström macroglobulinemia under rituximab-cyclophosphamide-dexamethasone.
    Aouba A; Pressiat C; Pricopi M; Georgin-Lavialle S; Boue F; Lievre-Castilla MA; Marfaing-Koka A; Prevot S; Decottignies A
    Dermatology; 2015; 230(1):18-22. PubMed ID: 25471063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schnitzler syndrome: response to anakinra in two cases and a review of the literature.
    Schuster C; Kränke B; Aberer E; Arbab E; Sturm G; Aberer W
    Int J Dermatol; 2009 Nov; 48(11):1190-4. PubMed ID: 20064173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Waldenström macroglobulinemia: my way.
    Gertz M
    Leuk Lymphoma; 2013 Mar; 54(3):464-71. PubMed ID: 22860921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete remission of Waldenström macroglobulinemia with azacitidine and rituximab.
    Weiss L; Melchardt T; Neureiter D; Kemmerling R; Moshir S; Pleyer L; Greil R; Egle A
    J Clin Oncol; 2011 Aug; 29(24):e696-8. PubMed ID: 21730268
    [No Abstract]   [Full Text] [Related]  

  • 5. Rituximab-induced life-threatening coagulopathy occurring in a patient with Waldenström macroglobulinemia treated with fludarabine, cyclophosphamide, and rituximab combination.
    Pilorge S; Park S; Dreyfus F; Bouscary D; Tamburini J
    Leuk Lymphoma; 2010 Dec; 51(12):2288-90. PubMed ID: 20929331
    [No Abstract]   [Full Text] [Related]  

  • 6. Schnitzler syndrome: treatment failure to rituximab but response to anakinra.
    Eiling E; Möller M; Kreiselmaier I; Brasch J; Schwarz T
    J Am Acad Dermatol; 2007 Aug; 57(2):361-4. PubMed ID: 17467852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transformation of IgM-MGUS into Waldenström´s macroglobulinemia in two of six patients treated for Schnitzler´s syndrome].
    Adam Z; Tomíška M; Řehák Z; Koukalová R; Krejčí M; Král Z; Adamová Z; Ševčíková S; Pour L; Štork M; Krejčí M; Sandecká V
    Vnitr Lek; 2021; 67(E-3):15-23. PubMed ID: 34171947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in the prognosis and treatment of Waldenström macroglobulinemia. Literature overview and own experience].
    Adam Z; Pour L; Krejčí M; Ševčíková S; Pourová E; Ševčíková E; Král Z; Mayer J
    Vnitr Lek; 2016 Jan; 62(1):25-39. PubMed ID: 26967234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of Bing-Neel syndrome using intrathecal chemotherapy and systemic combination chemotherapy followed by BEAM auto-transplant: a case report and review of literature.
    Abdallah AO; Atrash S; Muzaffar J; Abdallah M; Kumar M; Van Rhee F; Barlogie B
    Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):502-6. PubMed ID: 23747080
    [No Abstract]   [Full Text] [Related]  

  • 10. Pentostatin/cyclophosphamide with or without rituximab: an effective regimen for patients with Waldenstrom's macroglobulinemia/lymphoplasmacytic lymphoma.
    Hensel M; Villalobos M; Kornacker M; Krasniqi F; Ho AD
    Clin Lymphoma Myeloma; 2005 Sep; 6(2):131-5. PubMed ID: 16231851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fludarabine plus cyclophosphamide and rituximab in Waldenstrom macroglobulinemia: an effective but myelosuppressive regimen to be offered to patients with advanced disease.
    Tedeschi A; Benevolo G; Varettoni M; Battista ML; Zinzani PL; Visco C; Meneghini V; Pioltelli P; Sacchi S; Ricci F; Nichelatti M; Zaja F; Lazzarino M; Vitolo U; Morra E
    Cancer; 2012 Jan; 118(2):434-43. PubMed ID: 21732338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab plus cyclophosphamide and dexamethasone
    Xiong W; Lyu R; Yu Y; Wang T; Yan Y; Wang Y; Liu W; An G; Deng S; Xu Y; Sui W; Huang W; Zou D; Wang J; Qiu L; Yi S
    Haematologica; 2024 May; 109(5):1614-1618. PubMed ID: 38205507
    [No Abstract]   [Full Text] [Related]  

  • 13. Anakinra: an effective treatment in the Schnitzler syndrome.
    Vandenhende MA; Bentaberry F; Morlat P; Bonnet F
    Joint Bone Spine; 2011 Dec; 78(6):636-7. PubMed ID: 21550281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remission of Schnitzler syndrome after treatment with anakinra.
    Frischmeyer-Guerrerio PA; Rachamalla R; Saini SS
    Ann Allergy Asthma Immunol; 2008 Jun; 100(6):617-9. PubMed ID: 18592830
    [No Abstract]   [Full Text] [Related]  

  • 15. Dexamethasone, rituximab, and cyclophosphamide as primary treatment of Waldenström macroglobulinemia: final analysis of a phase 2 study.
    Kastritis E; Gavriatopoulou M; Kyrtsonis MC; Roussou M; Hadjiharissi E; Symeonidis A; Repoussis P; Michalis E; Delimpasi S; Tsatalas K; Tsirigotis P; Vassou A; Vervessou E; Katodritou E; Gika D; Terpos E; Dimopoulos MA
    Blood; 2015 Sep; 126(11):1392-4. PubMed ID: 26359434
    [No Abstract]   [Full Text] [Related]  

  • 16. Waldenström macroglobulinemia: 2015 update on diagnosis, risk stratification, and management.
    Gertz MA
    Am J Hematol; 2015 Apr; 90(4):346-54. PubMed ID: 25808108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous presentation of Waldenström macroglobulinemia and multiple myeloma: multidisciplinary diagnosis, treatment and 30-month follow-up.
    Carulli G; Ciancia EM; Azzarà A; Ottaviano V; Grassi S; Ciabatti E; Ferreri MI; Rocco M; Marini A; Petrini M
    J Clin Exp Hematop; 2013; 53(1):29-36. PubMed ID: 23801131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anakinra treatment in Schnitzler syndrome -  results of the first retrospective multicenter study in six patients from the Czech Republic].
    Szturz P; Sedivá A; Zurek M; Adam Z; Stork J; Cermáková Z; Steyerová P; Vokáčová A; Hrbek J; Sýkora M; Spička I; Mechl Z; Mayer J
    Klin Onkol; 2014; 27(2):111-26. PubMed ID: 24739048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dermal interleukin-1 expression and effective and long-lasting therapy with interleukin-1 receptor antagonist anakinra in Schnitzler syndrome.
    Volz T; Wölbing F; Fischer J; Braun M; Maggoschitz I; Schaller M; Berneburg M; Biedermann T
    Acta Derm Venereol; 2012 Jul; 92(4):393-4. PubMed ID: 22334118
    [No Abstract]   [Full Text] [Related]  

  • 20. Fludarabine, cyclophosphamide and rituximab (FCR) induced pulmonary hypertension in Waldenstrom macroglobulinemia.
    Lazarevic VLj; Liljeholm M; Forsberg K; Söderberg S; Wahlin A
    Leuk Lymphoma; 2008 Jun; 49(6):1209-11. PubMed ID: 18452089
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.